FLT3 and acute myeloid leukemia: To further evaluate the survival-inhibitory effects of either chidamide and/or FLT3 inhibitors or chemotherapy agents on the acquired resistant AML cells, we performed an apoptosis assay in the sorted BMMCs from the relapsed FLT3-ITD+ AML patients previously administrated with sorafenib plus HHT and Ara-C.